Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fabio Sonvico, Gaia Colombo, Eride Quarta, Fabiola Guareschi, Sabrina Banella, Francesca Buttini & Regina Scherließ. (2023) Nasal delivery as a strategy for the prevention and treatment of COVID-19. Expert Opinion on Drug Delivery 20:8, pages 1115-1130.
Read now
Read now
Klang Shmuel, Megiddo Dalia, Lapidot Tair & Naparstek Yaakov. (2021) Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey. Expert Review of Anti-infective Therapy 19:10, pages 1325-1330.
Read now
Read now
Articles from other publishers (2)
E. V. Blinova, G. K. Poluosmak, E. A. Litvin, D. S. Blinov, M. V. Shiсh, O. S. Vavilova, O. V. Vasilkina & E. V. Shich. (2023) Hypromellose improves mydriasis dynamics by phenylephrine in a rabbit experimental model. Russian Ophthalmological Journal 16:1, pages 119-126.
Crossref
Crossref
Kirsten Bentley & Richard J. Stanton. (2021) Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread. Viruses 13:12, pages 2345.
Crossref
Crossref